HMGCR and Oligomenorrhea: Through a large-scale MR analysis of female reproductive endocrine diseases using data from a Finnish database, we investigated the effects of three common drug targets (HMGCR, PCSK9, and NPC1L1) on various conditions including PCOS, POF, PMS, menorrhagia, oligomenorrhea, and infertility.